InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Wilms Joris. Director active across 1 company, notably Y-mAbs Therapeutics, Inc.. In total, 5 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €66k. Activity tracked since 17 January 2023. The latest transaction was disclosed on 16 September 2025 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Wilms Joris is a declarant linked to Y-MAbs Therapeutics, Inc. (XNAS). The record shows 4 filings in total, and across the sampled recent filings between 2023-01-19 and 2025-01-22, the sum of sales is EUR 65788, with the dominant transaction nature shown as Attribution.